Literature DB >> 7139604

Kinetic heterogeneity in density-separated murine fibrosarcoma subpopulations.

W A Brock, D E Swartzendruber, D J Grdina.   

Abstract

Murine fibrosarcoma cells can be separated into subpopulations by centrifugation through 10 to 35% Renografin density gradients. Previous work has shown that the heavier cell populations are rich in chronically hypoxic cells. In this study, each subpopulation was characterized for thymidine incorporation, thymidine transport, thymidine triphosphate pool sizes, and thymidine triphosphate specific activities. The heavier cell populations have less accessibility to exogenous thymidine, and they have lower endogenous pools of thymidine triphosphate and synthesize lower levels of DNA than do the lighter cell populations. However, if the cells are removed from the tumors and labeled with [3H]thymidine in vitro, all subpopulations synthesize DNA at similar rates. Two-parameter flow cytometry using acridine orange staining following partial acid denaturation of chromatin identified a small quiescent population in the most dense cell fraction, but the small number of these cells cannot account for the results of the biochemical studies. It appears that the hypoxic cells in the fibrosarcoma tumors are noncycling or slowly cycling, are in all phases of the cell cycle, and recover their ability to synthesize DNA when cultured under in vitro conditions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7139604

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Plasminogen activator activity in clonogenic cell populations separated from a murine fibrosarcoma.

Authors:  B Nagy; D J Grdina
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

2.  Density gradient centrifugation of tumor cells from needle biopsies and their respective source tumors: a comparison of density distributions.

Authors:  D J Grdina; G Zin
Journal:  Experientia       Date:  1983-08-15

Review 3.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  The Ki-67 antigen in primary human melanomas--its relationship to mitotic rate and tumor thickness and its stability.

Authors:  H Ostmeier; L Suter
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

5.  Cytotoxic effects of vincristine on tumour subpopulations separated from pulmonary nodules.

Authors:  D J Grdina; R A White; J J Stragand
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640

6.  Inhibition of cell-cycle progression by acute treatment with various degrees of hypoxia: modifications induced by low concentrations of misonidazole present during hypoxia.

Authors:  E O Pettersen; T Lindmo
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.